Serial 76608648
Live / Registered — Registered and renewed (as of 19 Apr 2017)
What this means for you
Registered since 01 May 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 May 2017).
Record
- Serial number
- 76608648
- Registration number
- 3235548
- Mark type
- Design / logo
- Filed
- 25 Aug 2004
- Published for opposition
- 13 Feb 2007
- Registered
- 01 May 2007
- Next maintenance due
- 01 May 2017
- Attorney of record
- Michele M. Glessner
Goods and services
- Class 001 — Chemicals: BIOCHEMICAL PREPARATIONS, NAMELY, MONOCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC OR RESEARCH USE, POLYCLONAL ANTIBODIES FOR IN VITRO SCIENTIFIC OR RESEARCH USE, RECOMBINANT PROTEIN, ENZYMES, RECOMBINANT HUMAN ENZYMES, RECOMBINANT HUMAN ENZYMES IN BACTERIA, RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES, METABOLITES, ALL FOR SCIENTIFIC OR RESEARCH USE; REAGENTS FOR USE IN DEVELOPMENT OF POLYCLONAL ANTIBODIES FOR SCIENTIFIC OR RESEARCH USE; BACTERIAL PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; ASSAYS FOR SCIENTIFIC OR RESEARCH USE
- Class 005 — Pharmaceuticals: [BIOCHEMICAL PREPARATIONS FOR MEDICAL OR VETERINARY USE, NAMELY, MONOCLONAL ANTIBODIES, POLYCLONAL ANTIBODIES, TAGGED ANTIBODIES, RECOMBINANT PROTEIN, ENZYMES, RECOMBINANT HUMAN ENZYMES, RECOMBINANT HUMAN ENZYMES IN BACTERIA, RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES; REAGENTS FOR USE IN DEVELOPMENT OF MONOCLONAL ANTIBODIES FOR MEDICAL USE; REAGENTS FOR USE IN DEVELOPMENT OF POLYCLONAL ANTIBODIES FOR MEDICAL USE; CHEMICAL PREPARATIONS CONTAINING ENZYMES FOR MEDICAL PURPOSES; CHEMICAL PREPARATIONS CONTAINING ENZYMES FOR PHARMACEUTICAL PURPOSES; ASSAYS FOR MEDICAL USE; BACTERIAL PRODUCTS, NAMELY, BACTERIAL CULTURES FOR MEDICAL USE; BACTERIAL PREPARATIONS FOR MEDICAL USE; BACTERIAL VACCINES FOR MEDICAL USE; BACTERIAL MEMBRANES FOR MEDICAL USE; REAGENTS IN KIT FORM FOR MEDICAL USE]
- Class 042 — Scientific and technological services: SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF BIOTECHNOLOGY, NAMELY, DRUG METABOLITE SYNTHESIS, HETEROLOGOUS PROTEIN EXPRESSION, IN VITRO DRUG METABOLISM SYSTEMS, PRODUCTION OF RECOMBINANT PROTEIN, PRODUCTION OF RECOMBINANT HUMAN ENZYMES, PRODUCTION OF RECOMBINANT HUMAN ENZYMES IN BACTERIA, PRODUCTION OF RECOMBINANT HUMAN DRUG-METABOLIZING ENZYMES; SCIENTIFIC RESEARCH CONSULTATION
Owner
- Cypex Limited, Dundee DD2 1NH, GB
- Cypex Limited, Dundee DD2 1TY, GB
- Cypex Limited, Dundee DD2 1TY, GB
Prosecution history
- 19 Apr 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Apr 2017 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Apr 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Apr 2017 — TEAS SECTION 8 & 9 RECEIVED
- 01 May 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 27 Aug 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 26 Aug 2012 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Aug 2012 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 26 Aug 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Aug 2012 — TEAS SECTION 8 & 15 RECEIVED
- 01 May 2007 — REGISTERED-PRINCIPAL REGISTER
- 13 Feb 2007 — PUBLISHED FOR OPPOSITION
- 24 Jan 2007 — NOTICE OF PUBLICATION
- 18 Dec 2006 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 15 Dec 2006 — APPROVED FOR PUB - PRINCIPAL REGISTER